171 related articles for article (PubMed ID: 21792076)
1. Systematic evaluation of genetic variants in three biological pathways on patient survival in low-stage non-small cell lung cancer.
Pankratz VS; Sun Z; Aakre J; Li Y; Johnson C; Garces YI; Aubry MC; Molina JR; Wigle DA; Yang P
J Thorac Oncol; 2011 Sep; 6(9):1488-95. PubMed ID: 21792076
[TBL] [Abstract][Full Text] [Related]
2. Association between genetic variants in pre-microRNAs and survival of early-stage NSCLC.
Hong MJ; Choi YY; Jang JA; Jung HJ; Lee SY; Lee WK; Yoo SS; Lee J; Cha SI; Kim CH; Lee E; Jeon HS; Son JW; Park JY
J Thorac Oncol; 2013 Jun; 8(6):703-10. PubMed ID: 23470291
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation in glutathione metabolism and DNA repair genes predicts survival of small-cell lung cancer patients.
Sun Z; Chen J; Aakre J; Marks RS; Garces YY; Jiang R; Idowu O; Cunningham JM; Liu Y; Pankratz VS; Yang P
Ann Oncol; 2010 Oct; 21(10):2011-2016. PubMed ID: 20439344
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D receptor genetic variants are associated with chemotherapy response and prognosis in patients with advanced non-small-cell lung cancer.
Xiong L; Cheng J; Gao J; Wang J; Liu X; Wang L
Clin Lung Cancer; 2013 Jul; 14(4):433-9. PubMed ID: 23522953
[TBL] [Abstract][Full Text] [Related]
5. The impact of functional LIG4 polymorphism on platinum-based chemotherapy response and survival in non-small cell lung cancer.
Jiang YH; Xu XL; Ruan HH; Xu WZ; Li D; Feng JG; Han QB; Mao WM
Med Oncol; 2014 May; 31(5):959. PubMed ID: 24722796
[TBL] [Abstract][Full Text] [Related]
6. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer.
Kalikaki A; Kanaki M; Vassalou H; Souglakos J; Voutsina A; Georgoulias V; Mavroudis D
Clin Lung Cancer; 2009 Mar; 10(2):118-23. PubMed ID: 19362955
[TBL] [Abstract][Full Text] [Related]
7. VCP gene variation predicts outcome of advanced non-small-cell lung cancer platinum-based chemotherapy.
Peng J; Yang LX; Zhao XY; Gao ZQ; Yang J; Wu WT; Wang HJ; Wang JC; Qian J; Chen HY; Jin L; Bai CX; Han BH; Wang WM; Lu DR
Tumour Biol; 2013 Apr; 34(2):953-61. PubMed ID: 23412975
[TBL] [Abstract][Full Text] [Related]
8. Genetic variations and patient-reported quality of life among patients with lung cancer.
Sloan JA; de Andrade M; Decker P; Wampfler J; Oswold C; Clark M; Yang P
J Clin Oncol; 2012 May; 30(14):1699-704. PubMed ID: 22454423
[TBL] [Abstract][Full Text] [Related]
9. Correlation of DNA Repair Gene Polymorphisms With Clinical Outcome in Patients With Locally Advanced Non-Small-Cell Lung Cancer Receiving Induction Chemotherapy Followed by Surgery.
Santarpia M; Ramirez JL; de Aguirre I; Garrido P; Pérez Cano M; Queralt C; Gonzalez-Larriba JL; Insa A; Provencio M; Isla D; Camps C; Blanco R; Moran T; Rosell R;
Clin Lung Cancer; 2017 Mar; 18(2):178-188.e4. PubMed ID: 27908619
[TBL] [Abstract][Full Text] [Related]
10. SNPs in the TGF-β signaling pathway are associated with increased risk of brain metastasis in patients with non-small-cell lung cancer.
Li Q; Wu H; Chen B; Hu G; Huang L; Qin K; Chen Y; Yuan X; Liao Z
PLoS One; 2012; 7(12):e51713. PubMed ID: 23284751
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in apoptosis-related genes and survival of patients with early-stage non-small-cell lung cancer.
Lee EB; Jeon HS; Yoo SS; Choi YY; Kang HG; Cho S; Cha SI; Choi JE; Park TI; Lee BH; Park RW; Kim IS; Kang YM; Kim CH; Jheon S; Jung TH; Park JY
Ann Surg Oncol; 2010 Oct; 17(10):2608-18. PubMed ID: 20422457
[TBL] [Abstract][Full Text] [Related]
12. AKT1 polymorphisms and survival of early stage non-small cell lung cancer.
Kim MJ; Kang HG; Lee SY; Jeon HS; Lee WK; Park JY; Lee EB; Lee JH; Cha SI; Kim DS; Kim CH; Kam S; Jung TH; Park JY
J Surg Oncol; 2012 Feb; 105(2):167-74. PubMed ID: 21842521
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 genetic variants are associated with survival in unresectable locally advanced non-small cell lung cancer.
Bi N; Yang M; Zhang L; Chen X; Ji W; Ou G; Lin D; Wang L
Clin Cancer Res; 2010 Apr; 16(8):2383-90. PubMed ID: 20332326
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in DNA repair and apoptosis-related genes and clinical outcomes of patients with non-small cell lung cancer treated with first-line paclitaxel-cisplatin chemotherapy.
Lee SY; Kang HG; Yoo SS; Kang YR; Choi YY; Lee WK; Choi JE; Jeon HS; Shin KM; Oh IJ; Kim KS; Lee J; Cha SI; Kim CH; Kim YC; Park JY
Lung Cancer; 2013 Nov; 82(2):330-9. PubMed ID: 23973201
[TBL] [Abstract][Full Text] [Related]
15. Exome-Wide Association Study Identifies Low-Frequency Coding Variants in 2p23.2 and 7p11.2 Associated with Survival of Non-Small Cell Lung Cancer Patients.
Zhu M; Geng L; Shen W; Wang Y; Liu J; Cheng Y; Wang C; Dai J; Jin G; Hu Z; Ma H; Shen H
J Thorac Oncol; 2017 Apr; 12(4):644-656. PubMed ID: 28104536
[TBL] [Abstract][Full Text] [Related]
16. Glucose Transporter 1 Gene Variants Predict the Prognosis of Patients with Early-Stage Non-small Cell Lung Cancer.
Do SK; Jeong JY; Lee SY; Choi JE; Hong MJ; Kang HG; Lee WK; Seok Y; Lee EB; Shin KM; Yoo SS; Lee J; Cha SI; Kim CH; Neugent ML; Goodwin J; Kim JW; Park JY
Ann Surg Oncol; 2018 Oct; 25(11):3396-3403. PubMed ID: 30062472
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of survivin polymorphisms on non-small cell lung cancer survival.
Dai J; Jin G; Dong J; Chen Y; Xu L; Hu Z; Shen H
J Thorac Oncol; 2010 Nov; 5(11):1748-54. PubMed ID: 20881643
[TBL] [Abstract][Full Text] [Related]
18. Role of EGFR SNPs in survival of advanced lung adenocarcinoma patients treated with Gefitinib.
Zhang L; Yuan X; Chen Y; Du XJ; Yu S; Yang M
Gene; 2013 Mar; 517(1):60-4. PubMed ID: 23313300
[TBL] [Abstract][Full Text] [Related]
19. Genetic Variant of Notch Regulator DTX1 Predicts Survival After Lung Cancer Surgery.
Lee JH; Shin KM; Lee SY; Hong MJ; Choi JE; Kang HG; Do SK; Lee WK; Lee EB; Seok Y; Jeong JY; Yoo SS; Lee J; Cha SI; Kim CH; Cho S; Jheon S; Kim YC; Oh IJ; Na KJ; Kim MS; Lee JM; Yang HC; Jung CY; Park CK; Lee MK; Kim DK; Park JY
Ann Surg Oncol; 2019 Oct; 26(11):3756-3764. PubMed ID: 31313037
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict platinum-based chemotherapy response of advanced non-small cell lung cancers in a Chinese population.
Xu JL; Wang ZW; Hu LM; Yin ZQ; Huang MD; Hu ZB; Shen HB; Shu YQ
Asian Pac J Cancer Prev; 2012; 13(5):2157-62. PubMed ID: 22901187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
